Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004478 · ClinicalTrials.gov registry record · NA
Droxidopa in Treating Patients With Neurogenic Hypotension
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
NCT00004478: Completed NA study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT00004478 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004478, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
Please note that the continuation study can be found at http://clinicaltrials.gov/show/NCT00633880. RATIONALE: Neurogenic hypotension is a fall in blood pressure that occurs when one moves from a lying down to a standing position or after eating a meal. It causes one to feel dizzy, light headed, and weak. Neurogenic hypotension is caused by a problem in the part of the nervous system that controls such functions as heart rate and blood pressure. Droxidopa, a drug that may increase blood pressure, may be an effective treatment for neurogenic hypotension. PURPOSE: Clinical trial to study the effectiveness of droxidopa in treating patients who have neurogenic hypotension.
Interventions
- DRUG droxidopa
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-03 |
| Est. Completion | 2006-03 |
| Phase | NA |
What the finished NCT00004478 record still lists
NCT00004478 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which droxidopa is the first listed.
NCT00004478 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004478 about?
NCT00004478 is a clinical study titled "Droxidopa in Treating Patients With Neurogenic Hypotension". Please note that the continuation study can be found at http://clinicaltrials.gov/show/NCT00633880. RATIONALE: Neurogenic hypotension is a fall in blood pressure that occurs when one moves from a lying down to a standing position or after eating a meal. It causes one to feel dizzy, light headed, an...
What is the current status of trial NCT00004478?
This trial is currently completed. It is a NA study. The study started on 1999-03. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00004478?
The interventions under investigation include: droxidopa (DRUG).
Who is sponsoring clinical trial NCT00004478?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia